Provided by Tiger Trade Technology Pte. Ltd.

Xencor

24.84
+0.07000.28%
Post-market: 25.230.3900+1.57%19:41 EDT
Volume:1.10M
Turnover:27.18M
Market Cap:1.84B
PE:-11.41
High:25.50
Open:25.36
Low:24.14
Close:24.77
52wk High:30.61
52wk Low:10.38
Shares:74.13M
Float Shares:54.25M
Volume Ratio:0.79
T/O Rate:2.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1768
EPS(LYR):-1.2400
ROE:-29.07%
ROA:-16.83%
PB:3.66
PE(LYR):-20.03

Loading ...

Xencor Settles Ultomiris U.S. Royalty Dispute with Alexion for USD 105 Million

Reuters
·
Jul 30

Xencor - First $52.50 Mln Payment Expected August 2026; Second Payment Due One Year Later

THOMSON REUTERS
·
Jul 30

Xencor - to Continue Receiving Royalties on Ex-U.S. Ultomiris Sales

THOMSON REUTERS
·
Jul 30

Xencor to Receive $105 Million from Alexion to Resolve Ultomiris® U.S. Royalty Matter

THOMSON REUTERS
·
Jul 30

Wedbush Reaffirms Their Buy Rating on Xencor (XNCR)

TIPRANKS
·
Jul 22

Xencor Inc : Leerink Partners Assumes Coverage with Outperform Rating; Target Price $29

THOMSON REUTERS
·
Jul 22

Is Xencor (XNCR) Quietly Recasting Its Platform As A Solid-Tumor Oncology Story?

Simply Wall St.
·
Jul 19

Xencor's Cancer Drug Study Selected for Oral Presentation at ESMO; Shares Rise

MT Newswires Live
·
Jul 18

Xencor to Present Phase 1 Xmab819 Data in Advanced Kidney Cancer at ESMO 2026

Reuters
·
Jul 17

Xencor Announces Proffered Paper Oral Presentation at Esmo 2026 for Phase 1 Clinical Study of Xmab819 in Advanced Clear Cell Renal Cell Carcinoma

THOMSON REUTERS
·
Jul 17

Xencor (XNCR) Rebounds Sharply, Is It Still A Bargain?

Simply Wall St.
·
Jul 11

Xencor price target lowered to $27 from $29 at Truist

TIPRANKS
·
Jul 07

Xencor is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

Xencor director Ellen Feigal disposes of 6,843 common shares worth $89,351.58

Reuters
·
Jun 23

Xencor Shareholders Approve Directors, Incentive Plan Amendments

TIPRANKS
·
Jun 19

Xencor shareholders approve 4 million-share increase under 2023 equity incentive plan

Reuters
·
Jun 19

Xencor director Alan Bruce Montgomery sells 5,064 shares worth $62,337.84

Reuters
·
Jun 18

Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Xencor (XNCR) and Definitive Healthcare Corp (DH)

TIPRANKS
·
Jun 16

MindWalk publishes Discovery-to-Clinic presentation factsheet

Reuters
·
May 18

Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)

TIPRANKS
·
May 14